Medical News

RSS

Service Employees International Union illegally collect Kansas healthcare workers' information

The Alliance for Worker Freedom (AWF) calls on Kansas Governor Mark Parkinson (D) to make information available regarding his Department's use of state resources and taxpayer money to obtain personal contact information of healthcare providers on behalf of the Service Employees International Union / SEIU Kansas.

15 Sep 2009

CBI's October Summit to discuss import-export regulation chain safety and security issues

The Center for Business Intelligence (CBI), a division of Advanstar Communications, is pleased to host their October Summit taking place at the Marriott Tyson's Corner, on October 22-23, 2009. Thought leaders from the importing and exporting compliance space from leading pharmaceutical and biotech companies assemble to discuss timely issues surrounding import-export regulation chain safety and security in this industry.

15 Sep 2009

Palatin Technologies to announce clinical trial results of PL-3994

Palatin Technologies, Inc. (NYSE Amex: PTN) announced that a poster on clinical trial results with PL-3994, its product for heart failure, will be presented today at the 13th Annual Scientific Meeting of the Heart Failure Society of America in Boston.

15 Sep 2009

Andersonville Arts Weekend art sales proceeds to support HIV-affected families

During the Arts weekend, over 25 of Olmetti's works and installations will be featured at SIR Spa. Proceeds from art sales will benefit the Chicago House, in support pf the mission of Chicago House and Social Service Agency to provide housing and supportive services to HIV-affected families and individuals who may also be impacted by poverty, homelessness, substance abuse, and mental illness.

15 Sep 2009

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

iMedicor and Transgenomic today announced that they have signed an agreement to develop an educational marketing program for NuroPro, Transgenomic’s diagnostic tests for Alzheimer’s and Parkinson’s disease.

15 Sep 2009

Implantable defibrillator therapy not beneficial for women with heart failure

Implantable cardioverter-defibrillators do not appear to be associated with a reduced risk of death in women with advanced heart failure, according to a meta-analysis of previously published research in the September 14 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

15 Sep 2009

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that it has signed binding letters of intent with three partners who will exclusively represent BioCryst and its anti-viral peramivir for influenza stockpiling opportunities, as well as for marketing and distribution of peramivir for seasonal influenza upon local regulatory approval, within their territories outside the U.S.

15 Sep 2009

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today that the company’s Tryton Side Branch Stent has been used in 250 procedures to treat atherosclerotic lesions at a bifurcation in patients with heart disease.

15 Sep 2009

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

The National Minority Quality Forum (NMQF), one of the nation's leading voices in the health disparities discussion, is launching the P.A.D. Atlas, a database that maps by zip code peripheral arterial disease (P.A.D.) prevalence down to the street level, with the P.A.D. Coalition and support from the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership.

15 Sep 2009

Mantra medicine tool helps patients in healing process

Dr. Mitchell Earl Gibson, a board-certified medical doctor in High Point, North Carolina, has formed a company that creates mantra and prayer-meditation-based recordings.

15 Sep 2009

Halozyme Therapeutics to present its product development pipeline

Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced its participation in the UBS Global Life Sciences Conference to be held on September 21-23, 2009 in New York City.

15 Sep 2009

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced the results of its first DRTV test week.

15 Sep 2009

New hydrogel mats extends anti-infection protection

Treatment of hospital-related infections in the U.S. costs up to $11 billion a year and about half of those infections are related to medical devices implanted in patients. Until now, efforts to control drug-resistant biofilms on such devices have been largely unsuccessful.

15 Sep 2009

RAPS honors award recipients for contributions to healthcare product regulatory profession

The Regulatory Affairs Professionals Society (RAPS) today honored the recipients of its prestigious awards for outstanding contributions to the healthcare product regulatory profession. RAPS' Leonard Stauffer Award for mentoring and furthering regulatory professional education was given to independent consultant Nanci Dexter.

15 Sep 2009

RED Light energy drink aims to add more corporate accounts

In a market saturated with energy drinks and shots, entrepreneur Paul Ebrahimian knew he was in for a challenge when he founded RED Light(R). However, he had the recipe for a great-tasting beverage, a smart business plan in place and the marketing vision to position RED Light as THE drink of choice--not just for energy, but also as an elixir.

15 Sep 2009

The University City Science Center contributes significantly to regional economy

Graduate organizations and current residents of the University City Science Center’s business incubators have created more than 15,000 jobs that remain in the Greater Philadelphia region today and contribute more than $9 billion to the regional economy annually, according to a study measuring the economic impact of the Science Center’s business incubation services that was released September 14, 2009.

15 Sep 2009

HTDS denies allegations of issuers regarding improper promotions

HTDS- The issuers received a certain e-mail after the market closed on September 14 2009 where amongst other things Pink Sheets claims that it has received complaints about improper promotions.

15 Sep 2009

Elekta announces interim results

Demand for Elekta’s clinical solutions, products and services remained strong in the first three months of 2009/10. Order bookings rose by 19 percent in local currency with solid performance in all regions. Net sales grew to SEK 1,440 M and operating result rose to SEK 89 M. Earnings per share improved to SEK 0.62 from SEK 0.02.

From Elekta 15 Sep 2009

Extension study data on Fampridine-SR drug

Data from two long-term open-label extension studies of Fampridine-SR show that 86.0% of participants remained on therapy after a maximum treatment time of 15 months in study MS-F204EXT, and 69.5% remained on therapy after a maximum treatment time of 36 months in study MS-F203EXT.

15 Sep 2009

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

CPEX Pharmaceuticals, Inc. (“CPEX”) today announced that it will participate in the Ninth Annual Diabetes Technology Meeting to be held November 5–7, 2009, at the Hyatt Regency Airport in San Francisco, California. Dr. Lance Berman, Senior Vice President and Chief Medical Officer, is scheduled to present an oral presentation titled “The Technology and Clinical Aspects of Nasal Insulin Therapy” at 9:30 a.m. PST on Saturday, November 7, 2009.

15 Sep 2009

Medical News

Service Employees International Union illegally collect Kansas healthcare workers' information

CBI's October Summit to discuss import-export regulation chain safety and security issues

Palatin Technologies to announce clinical trial results of PL-3994

Andersonville Arts Weekend art sales proceeds to support HIV-affected families

iMedicor and Transgenomic to develop an educational marketing program for NuroPro

Implantable defibrillator therapy not beneficial for women with heart failure

Biocryst signs agreement with three partners to represent its anti-viral peramivir outside U.S.

Tryton Side Branch Stent used in 250 procedures to treat atherosclerotic lesions

NMQF launches the P.A.D. Atlas database that maps peripheral arterial disease prevalence by zip code

Mantra medicine tool helps patients in healing process

Halozyme Therapeutics to present its product development pipeline

Neuroskin Psoriasis Relief DRTV test results announced by avVaa World Health Care

New hydrogel mats extends anti-infection protection

RAPS honors award recipients for contributions to healthcare product regulatory profession

RED Light energy drink aims to add more corporate accounts

The University City Science Center contributes significantly to regional economy

HTDS denies allegations of issuers regarding improper promotions

Elekta announces interim results

Extension study data on Fampridine-SR drug

CPEX Pharmaceuticals to discuss the clinical aspects of nasal insulin therapy

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News